Strategic Expansion Minakem operates across four sites in France, Belgium, and Canada with FDA approvals, enabling regional production capabilities and potential nearshoring options for customers seeking diversified supply chains and cross-site manufacturing support.

High Potent API Focus Specialization in high potency APIs, complex multi-step synthesis, and niche chemistries including prazole, steroid, chiral, and halogenation chemistry positions Minakem as a partner for oncology and specialty therapeutic programs requiring advanced manufacturing and QA/regulatory capabilities.

Integrated Development End-to-end services from process development and optimization to custom manufacturing and key intermediate production create a one-stop solution for pharma customers looking to reduce handoffs, accelerate timelines, and ensure robust regulatory compliance.

Industry Recognition Recent EcoVadis Gold Medal and Pierre Potier prize recognition underscore sustainability leadership and innovation, which can be leveraged to differentiate offering to ESG-conscious clients and government-funded projects.

Minafin Synergy Being part of the Minafin Group expands access to broader technologies, resources, and geographic links (Leuna, Pennakem) for joint ventures, co-development, and optimized supply chain solutions that appeal to global pharma manufacturers seeking scalable partnerships.